Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease.
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
- Post author:Randy Banks
- Post published:March 13, 2023
- Post category:News